Cargando…
Is pentraxin 3 level an effective biomarker in disease activity in patients with rheumatoid arthritis?
INTRODUCTION: The aim of the current study was to identify whether serum pentraxin 3 (PTX3) level could be a marker of increased inflammation in rheumatoid arthritis (RA) patients. MATERIAL AND METHODS: The study included 41 patients diagnosed with RA according to the American College of Rheumatolog...
Autores principales: | Balbaloglu, Ozlem, Ozcan, Seda Sabah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963156/ https://www.ncbi.nlm.nih.gov/pubmed/32051709 http://dx.doi.org/10.5114/aoms.2017.69726 |
Ejemplares similares
-
Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
por: Deyab, Gia, et al.
Publicado: (2017) -
Circulating and Synovial Pentraxin-3 (PTX3) Expression Levels Correlate With Rheumatoid Arthritis Severity and Tissue Infiltration Independently of Conventional Treatments Response
por: Boutet, Marie-Astrid, et al.
Publicado: (2021) -
Pentraxin 3 Plasma Levels and Disease Activity in Systemic Lupus Erythematosus
por: Assandri, Roberto, et al.
Publicado: (2015) -
Association of Periodontitis with Rheumatoid Arthritis and the Effect of Non-Surgical Periodontal Treatment on Disease Activity in Patients with Rheumatoid Arthritis
por: Zhao, Xinyuan, et al.
Publicado: (2018) -
Pentraxin 3: A Novel Biomarker for Inflammatory Cardiovascular Disease
por: Inoue, Kenji, et al.
Publicado: (2012)